Natriuretic Peptide Clearance Receptor (NPR-C) Pathway as a Novel Therapeutic Target in Obesity-Related Heart Failure With Preserved Ejection Fraction (HFpEF).

Frontiers in Physiology
Emmanuel Eroume A Egom

Abstract

Heart failure (HF) with preserved ejection fraction (HFpEF) is a major public health problem with cases projected to double over the next two decades. There are currently no US Food and Drug Administration-approved therapies for the health-related outcomes of HFpEF. However, considering the high prevalence of this heterogeneous syndrome, a directed therapy for HFpEF is one the greatest unmet needs in cardiovascular medicine. Additionally, there is currently a lack of mechanistic understanding about the pathobiology of HFpEF. The phenotyping of HFpEF patients into pathobiological homogenous groups may not only be the first step in understanding the molecular mechanism but may also enable the development of novel targeted therapies. As obesity is one of the most common comorbidities found in HFpEF patients and is associated with many cardiovascular effects, it is a viable candidate for phenotyping. Large outcome trials and registries reveal that being obese is one of the strongest independent risk factors for developing HFpEF and that this excess risk may not be explained by traditional cardiovascular risk factors. Recently, there has been increased interest in the intertissue communication between adipose tissue and the heart. E...Continue Reading

References

Oct 1, 1992·The New England Journal of Medicine·E D FrohlichB Massie
Sep 1, 1989·Proceedings of the Society for Experimental Biology and Medicine·D L CrandallP Cervoni
May 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·T Katada, M Ui
Jan 17, 1995·Annals of the New York Academy of Sciences·M FuruyaH Matsuo
Nov 30, 1994·Biochemical and Biophysical Research Communications·C M WeiJ C Burnett
Jun 23, 1999·Proceedings of the National Academy of Sciences of the United States of America·N MatsukawaO Smithies
Jan 24, 2002·Nature·Stanley Nattel
May 23, 2002·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Victor H CascoAdolfo J de Bold
Dec 14, 2002·Circulation Research·Toshihiro TsurudaJohn C Burnett
Apr 5, 2003·American Journal of Physiology. Cell Physiology·Huiping Zhou, Karnam S Murthy
Feb 26, 2004·Obesity Research·Riccardo SarzaniAlessandro Rappelli
May 7, 2004·The New England Journal of Medicine·Michael R ZileWilliam H Gaasch
Jan 27, 2005·Pharmacology & Therapeutics·Ramona S ScotlandAdrian J Hobbs
Nov 8, 2005·Lancet·Charlotte Kragelund, Torbjørn Omland
Jan 27, 2006·European Journal of Clinical Investigation·C ChristoffersenL B Nielsen
Mar 3, 2006·The Journal of Clinical Investigation·Brian N Finck, Daniel P Kelly
Jun 21, 2006·Molecular and Cellular Biochemistry·William R GowerSuzanne M Solivan
Jul 21, 2006·The New England Journal of Medicine·Theophilus E OwanMargaret M Redfield
Jan 6, 2007·Journal of Cardiovascular Pharmacology·Christian M MatterThomas F Lüscher
Sep 22, 2007·Journal of Molecular and Cellular Cardiology·Osamu WakisakaHironobu Yoshimatsu
Feb 22, 2008·Nature·James O Mudd, David A Kass
Aug 16, 2008·Journal of the American College of Cardiology·Sheldon E Litwin
Jan 12, 2010·Biochemical and Biophysical Research Communications·Hideaki NakatsujiIichiro Shimomura
May 28, 2010·Journal of Cellular Physiology·Brenda K HuntleyJohn C Burnett
Jan 18, 2011·Regulatory Peptides·Everaldo Nery de AndradeNajara de Oliveira Belo
Mar 8, 2011·The FEBS Journal·Lincoln R Potter
Jul 26, 2011·The Journal of Clinical Investigation·Paari Dominic SwaminathanMark E Anderson
Aug 10, 2011·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Camilla CalvieriMassimo Volpe
Sep 17, 2011·Circulation. Heart Failure·Alanna M ChamberlainVéronique L Roger
Feb 7, 2012·The Journal of Clinical Investigation·Marica BordicchiaSheila Collins
May 19, 2012·Circulation Research·Steven R HouserUNKNOWN American Heart Association Council on Basic Cardiovascular Sciences, Council on Clinical Cardiology, and Council on Function
Feb 15, 2013·Circulation. Arrhythmia and Electrophysiology·Akira FukuiTetsunori Saikawa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.